CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award Director acquired 99 shares (grant or award)
- 4 Planned sale EVP Research & Development sold 2,000 shares at $60.56 ($121,120)
- 4 Planned sale Director sold 6,757 shares at $60.00 ($405,420)
- 4 Planned sale President & CEO sold 5,000 shares at $55.05 ($275,250)
- 4 Planned sale Director sold 6,695 shares at $55.08 ($368,761)
- 4 Planned sale EVP Research & Development sold 2,000 shares at $49.28 ($98,560)
- 4 Planned sale President & CEO sold 5,000 shares at $49.77 ($248,850)
- 4 Planned sale EVP Research & Development sold 2,000 shares at $51.29 ($102,580)
- 4 Planned sale Director sold 6,756 shares at $50.00 ($337,800)
- 4 Planned sale Director sold 2,150 shares at $48.67 ($104,641)
- 4 Planned sale President & CEO sold 5,000 shares at $48.76 ($243,800)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP Research & Development sold 2,000 shares at $38.31 ($76,620)
- 4 Planned sale President & CEO sold 5,000 shares at $38.42 ($192,100)
- 4 Planned sale EVP Research & Development sold 2,000 shares at $36.34 ($72,680)
- 4 Planned sale President & CEO sold 5,000 shares at $36.45 ($182,250)
- 4 Planned sale EVP Research & Development sold 2,000 shares at $37.47 ($74,940)
- 4 Grant or award Director acquired 559 shares (grant or award)
- 4 Grant or award Director acquired 164 shares (grant or award)
Page 8 of 70 · 1,399 filings